Introduction {#Sec1}
============

Citrate synthase (CS, EC 2.3.3.1) catalyses the first reaction of the tricarboxylic acid (TCA) cycle: oxaloacetate + acetyl-CoA + H~2~O → citrate + CoA-SH. Different bacterial CSs have been characterised, and studies have shown that the biochemical properties of CSs from Gram-positive bacteria and Gram-negative bacteria exhibit some differences. CSs from Gram-negative bacteria are inhibited by NADH, whereas CSs from Gram-positive bacteria are not^[@CR1],[@CR2]^. However, the biochemical properties of cyanobacterial CSs have not been well-characterised.

Photoautotrophic cyanobacteria have been evaluated for use in the sustainable production of bioplastics and biofuels from carbon dioxide using light energy^[@CR3]^. *Synechocystis* sp. PCC 6803 (hereafter, *Synechocystis* 6803) is a unicellular cyanobacterium that has been widely studied for use in metabolite production. *Synechocystis* 6803 exhibits suitable characteristics as a host for metabolite production such as rapid growth and natural transformation capability^[@CR4]^. *Synechocystis* 6803 can be repeatedly genetically manipulated^[@CR5]^. Various genetic toolsets have been developed for *Synechocystis* 6803^[@CR6]^. This freshwater cyanobacterium can also grow in artificial seawater supplemented with nitrogen and phosphorus^[@CR7]^. Under dark and anaerobic conditions, *Synechocystis* 6803 produces organic acids such as [d]{.smallcaps}-lactate and succinate, which are used in bioplastics production (Fig. [1](#Fig1){ref-type="fig"})^[@CR8]^. In *Synechocystis* 6803, biochemical analyses of a phosphoenolpyruvate carboxylase (encoded by *pps*, sll0920) being the rate-limiting enzyme in succinate production^[@CR9],[@CR10]^ and [d]{.smallcaps}-lactate dehydrogenase (encoded by *ddh*, slr1556) catalysing the final reaction in [d]{.smallcaps}-lactate production have been performed (Fig. [1](#Fig1){ref-type="fig"})^[@CR11],[@CR12]^. These reports identified the enzymatic properties and the critical amino acid residues regulating the enzymatic activities, and emphasised the importance of biochemical studies of this cyanobacterium^[@CR11],[@CR12]^. For example, we have previously indicated that lower activity of [d]{.smallcaps}-lactate dehydrogenase (Ddh) from *Synechocystis* 6803 compared to other bacterial Ddh is one of the weak point of [d]{.smallcaps}-lactate production using *Synechocystis* 6803^[@CR12]^. We have indicated that Ddh from *Synechocystis* 6803 also catalyses the reaction from oxaloacetate to malate and an amino acid substitution alters the substrate specificity of Ddh^[@CR12]^.Figure 1Metabolic map around the TCA cycle in *Synechocystis* sp. PCC 6803. The information of genes encoding enzymes in *Synechocystis* sp. PCC 6803 were obtained by Kyoto Encyclopedia of Genes and Genomes (KEGG) database (<http://www.genome.jp/kegg/>). The green squares represent the useful metabolites having been reported previously. The blue dotted lines represent the synthetic reactions being catalysed by foreign enzymes. 3HB: 3-hydroxybutyrate, 3HP: 3-hydroxypropionic acid, PHB: polyhydroxybutyrate.

Characterising acetyl-CoA metabolism and the enzymes involved is crucial for understanding the basic science of cyanobacteria and its potential practical applications. The intracellular acetyl-CoA concentration of *Synechocystis* 6803 is much higher compared to those of other cyanobacteria^[@CR13]^. The production of polyhydroxybutyrate (PHB)^[@CR14]--[@CR16]^, 3-hydroxybutyrate (3HB)^[@CR17]^, *n*-butanol^[@CR18]^, and 3-hydroxypropionic acid (3HP)^[@CR19],[@CR20]^ from acetyl-CoA in *Synechocystis* 6803 has been studied (Fig. [1](#Fig1){ref-type="fig"}). Ethylene production from the TCA cycle intermediates in *Synechocystis* 6803 has also been demonstrated (Fig. [1](#Fig1){ref-type="fig"})^[@CR21],[@CR22]^. Despite these metabolic engineering applications, few studies have conducted biochemical analysis using acetyl-CoA as a substrate in cyanobacterium. In this study, we performed biochemical analyses of *Sy*CS (encoded by *gltA*, sll0401) (Fig. [1](#Fig1){ref-type="fig"}) and compared its properties with those of other bacterial CSs.

Results {#Sec2}
=======

Purification and kinetic analyses of *Sy*CS {#Sec3}
-------------------------------------------

For biochemical analysis of *Sy*CS, glutathione-*S*-transferase (GST)-tagged *Sy*CS was purified from *Escherichia coli* by affinity chromatography (Fig. [2a](#Fig2){ref-type="fig"}). The optimal conditions at which *Sy*CS showed maximal activity were 37 °C and pH 7.5 (Fig. [2b,c](#Fig2){ref-type="fig"}). Therefore, subsequent analysis of *Sy*CS was conducted under these conditions. To calculate the kinetic parameters of *Sy*CS, saturation curves of *Sy*CS for both substrates were drawn (Fig. [3](#Fig3){ref-type="fig"}). The observed *K*~m~ value of *Sy*CS for oxaloacetate was 91 ± 11 μM and the *k*~cat~ value for oxaloacetate was 2.76 ± 0.26 s^−1^ (Table [1](#Tab1){ref-type="table"}). The *k*~cat~/*K*~m~ value of *Sy*CS for oxaloacetate was 30.50 ± 3.17 s^−1^mM^−1^ (Table [1](#Tab1){ref-type="table"}). Similarly, for acetyl-CoA, the *K*~m~ value was 220 ± 77 μM and the *k*~cat~ value was 2.51 ± 0.24 s^−1^ (Table [1](#Tab1){ref-type="table"}). The *k*~cat~/*K*~m~ value of *Sy*CS for acetyl-CoA was 12.07 ± 2.95 s^−1^mM^−1^ (Table [1](#Tab1){ref-type="table"}). *Sy*CS showed no catalytic activity for the backward reaction, generating acetyl-CoA and oxaloacetate from citrate and CoA.Figure 2Effect of temperature and pH on *Sy*CS activity. (**a**) SDS-PAGE analysis after affinity purification of GST-tagged *Sy*CS. The purified proteins were electrophoresed by 12% SDS-PAGE and stained with InstantBlue reagent. Arrows (blue) indicate the positions of molecular protein markers. (**b**) *Sy*CS activity at different temperatures. The experiment was conducted using 150 pmol of *Sy*CS at pH 7.5. The concentrations of oxaloacetate and acetyl-CoA were 1 and 0.5 mM, respectively. *Sy*CS activity was set to 100% at 37 °C. The data represent the mean ± SD from three independent experiments. (**c**) *Sy*CS activity at different pH values. The experiment was conducted using 150 pmol of *Sy*CS, and the temperature was 37 °C. The concentrations of oxaloacetate and acetyl-CoA were 1 and 0.5 mM, respectively. *Sy*CS activity was set to 100% at pH 7.5. The data represent the mean ± SD from three independent experiments.Figure 3Saturation curves of *Sy*CS for oxaloacetate (left) and acetyl-CoA (right). The experiment was conducted using 50 pmol of *Sy*CS at 37 °C, pH 7.5. The concentrations of oxaloacetate and acetyl-CoA were set to 1 and 0.5 mM, respectively. The data represent the mean ± SD from three independent experiments.Table 1Kinetic parameters of *Sy*CS for oxaloacetate and acetyl-CoA.SubstrateEffector*K*~m~ (μM)*k*~cat~ (s^−1^)*k*~cat~/*K*~m~ (s^−1^mM^−1^)OxaloacetateNone91 ± 112.76 ± 0.2630.50 ± 3.175 mM ADP73 ± 113.35 ± 0.5445.65 ± 0.84^\*^3 mM PEP108 ± 41.53 ± 0.06^\*^14.19 ± 0.99^\*^Acetyl-CoANone220 ± 772.51 ± 0.2412.07 ± 2.955 mM ADP153 ± 242.99 ± 0.1219.90 ± 2.82^\*^3 mM PEP194 ± 361.42 ± 0.18^\*^7.39 ± 0.70The experiment was conducted using 50 pmol of *Sy*CS, and enzymatic activity was measured under optimal conditions (37 °C and pH 7.5). The concentrations of oxaloacetate or acetyl-CoA were 1 and 0.5 mM, respectively. The data represent the mean ± SD from three independent experiments. The asterisks indicated significant differences between the absence and presence of the effector (Student's *t* test; \**P* \< 0.05).

Effects of ions on *Sy*CS activity {#Sec4}
----------------------------------

The effects of monovalent and divalent salts on *Sy*CS activity were examined. *Sy*CS activity was altered by monovalent and divalent salts, which was affected by the concentration of substrates (Fig. [4](#Fig4){ref-type="fig"}). At a saturated concentration of both substrates in the absence of effectors, *Sy*CS activity increased to 188% in the presence of 100 mM KCl, 205% in the presence of 100 mM NaCl, 391% in the presence of 100 mM MgCl~2~, and 251% in the presence of 100 mM CaCl~2~, while enzyme activity was decreased to 48% in the presence of 100 mM MnCl~2~ (Fig. [4](#Fig4){ref-type="fig"}). At the half-saturated concentration of both substrates in the absence of effectors, *Sy*CS activity increased to 345% in the presence of 100 mM KCl, 336% in the presence of 100 mM NaCl, 1,463% in the presence of 100 mM MgCl~2~, and 1,050% in the presence of 100 mM CaCl~2~, while enzyme activity was decreased to 37% in the presence of 100 mM MnCl~2~ (Fig. [4](#Fig4){ref-type="fig"}).Figure 4Effect of monovalent and divalent salts on *Sy*CS activity. The experiment was conducted using 50 pmol of *Sy*CS at 37 °C, pH 7.5. The concentrations of monovalent and divalent salts were set to 100 mM. Oxaloacetate and acetyl-CoA were set to the saturated concentrations (left bars; 1 and 0.5 mM, respectively), and the *K*~m~ values (right bars; 0.091 and 0.220 mM, respectively). *Sy*CS activity in the absence of monovalent and divalent salts was set to 100%. The data represent the mean ± SD from three independent experiments. The asterisks indicate significant differences between the absence and presence of the salt (Student's *t* test; \**P* \< 0.05, \*\**P* \< 0.005).

The activation of *Sy*CS by monovalent and divalent salts was affected by the pH (Fig. [5](#Fig5){ref-type="fig"}). In KCl, *Sy*CS activation was concentration-dependent at both pH 7.0 and pH 8.5 (Fig. [5a](#Fig5){ref-type="fig"}). The activity of *Sy*CS increased linearly with increasing concentrations of NaCl at pH 7.0 (Fig. [5b](#Fig5){ref-type="fig"}). At pH 8.5, *Sy*CS activity did not increase up to 50 mM NaCl; however, it increased by 2.4-fold in the presence of 100 mM NaCl (Fig. [5b](#Fig5){ref-type="fig"}). The activation of *Sy*CS by 100 mM monovalent salts at pH 8.5 was greater than that at pH 7.0 (Fig. [5a,b](#Fig5){ref-type="fig"}). The activation of *Sy*CS peaked at 20 mM MgCl~2~ at both pH 7.0 and pH 8.5 (Fig. [5c](#Fig5){ref-type="fig"}). The activation of *Sy*CS peaked at 20 mM CaCl~2~ at pH 8.5 and at 50 mM CaCl~2~ at pH 7.0 (Fig. [5d](#Fig5){ref-type="fig"}). In contrast to monovalent salts, the activation of *Sy*CS by 100 mM divalent salts at pH 7.0 was greater than that at pH 8.5 (Fig. [5c,d](#Fig5){ref-type="fig"}).Figure 5Effect of pH on activation of *Sy*CS by (**a**) KCl, (**b**) NaCl, (**c**) MgCl~2~, and (**d**) CaCl~2~. The experiment was conducted using 50 pmol of *Sy*CS at 37 °C, pH 7.0 or 8.5. The concentrations of oxaloacetate and acetyl-CoA were 1 and 0.5 mM. *Sy*CS activity in the absence of monovalent and divalent salts was set to 100%. The data represent the mean ± SD from three independent experiments.

Regulation of *Sy*CS activity by metabolites {#Sec5}
--------------------------------------------

*Sy*CS activity was also altered by different metabolites (Fig. [6](#Fig6){ref-type="fig"}). In the presence of 5 mM phosphoenolpyruvate (PEP), citrate (CIT), and 2-oxoglutarate (2OG), *Sy*CS activity markedly decreased to 14%, 1%, and 2%, respectively (Fig. [6](#Fig6){ref-type="fig"}). Although PEP is a metabolite in glycolysis, it inhibited *Sy*CS activity (Fig. [6](#Fig6){ref-type="fig"}). To examine the changes in the kinetic parameters of *Sy*CS, saturation curves of *Sy*CS for both substrates in the presence of 3 mM PEP were drawn (Fig. [3](#Fig3){ref-type="fig"}). In the presence of 3 mM PEP, the *K*~m~ value of *Sy*CS for oxaloacetate was 108 ± 4 μM, the *k*~cat~ value of *Sy*CS for oxaloacetate decreased to 1.53 ± 0.06 s^−1^, and the *k*~cat~/*K*~m~ value of *Sy*CS for oxaloacetate decreased to 14.19 ± 0.99 s^−1^mM^−1^ (Table [1](#Tab1){ref-type="table"}). In the presence of 3 mM PEP, the *K*~m~ value of *Sy*CS for acetyl-CoA was 194 ± 36 μM, the *k*~cat~ value of *Sy*CS for acetyl-CoA decreased to 1.42 ± 0.18 s^−1^, and the *k*~cat~/*K*~m~ value of *Sy*CS for acetyl-CoA was 7.39 ± 0.70 s^−1^mM^−1^ (Table [1](#Tab1){ref-type="table"}). In contrast, *Sy*CS activity significantly increased to 369% in the presence of 5 mM ADP (Fig. [6](#Fig6){ref-type="fig"}). To examine changes in the kinetic parameters of *Sy*CS, the saturation curves of *Sy*CS for both substrates in the presence of 5 mM ADP were drawn (Fig. [3](#Fig3){ref-type="fig"}). In the presence of 5 mM ADP, the *K*~m~ value of *Sy*CS for oxaloacetate was 73 ± 11 μM, the *k*~cat~ value of *Sy*CS for oxaloacetate was 3.35 ± 0.54 s^−1^, and the *k*~cat~/*K*~m~ value of *Sy*CS for oxaloacetate increased to 45.65 ± 0.84 s^−1^mM^−1^ (Table [1](#Tab1){ref-type="table"}). In the presence of 5 mM ADP, the *K*~m~ value of *Sy*CS for acetyl-CoA was 153 ± 24 μM, the *k*~cat~ value of *Sy*CS for acetyl-CoA was 2.99 ± 0.12 s^−1^, and the *k*~cat~/*K*~m~ value of *Sy*CS for acetyl-CoA increased to 19.90 ± 2.82 s^−1^mM^−1^ (Table [1](#Tab1){ref-type="table"}). Compounds related to the TCA cycle and amino acid metabolism \[pyruvate (PYR), succinate (SUC), fumarate (FUM), [l-]{.smallcaps}malate (MAL), and [l-]{.smallcaps}aspartate (ASP)\] and nucleotides (ATP, AMP, NADH, NAD^+^, NADPH, and NADP^+^) did not significantly alter *Sy*CS activity (Fig. [6](#Fig6){ref-type="fig"}).Figure 6Effect of metabolites on *Sy*CS activity. The experiment was conducted using 50 pmol of *Sy*CS at 37 °C, pH 7.5. The concentrations of oxaloacetate and acetyl-CoA were the *K*~m~ values, 0.091 and 0.220 mM, respectively. Concentrations of the metabolites were 5 mM. *Sy*CS activity in the absence of metabolites was set to 100%. The data represent the mean ± SD from three independent experiments. PEP: Phosphoenolpyruvate, PYR: Pyruvate, CIT: Citrate, 2OG: 2-Oxoglutarate, SUC: Succinate, FUM: Fumarate, MAL: [l-]{.smallcaps}Malate, ASP: [l-]{.smallcaps}Aspartate. The asterisks indicate significant differences between the absence and presence of the metabolite (Student's *t* test; \**P* \< 0.05).

Discussion {#Sec6}
==========

We purified and biochemically characterised CS from the cyanobacterium *Synechocystis* sp. PCC 6803 in this study. The *k*~cat~ value of *Sy*CS was lower than those of reported CSs from heterotrophic bacteria (8--263 s^−1^)^[@CR23]--[@CR26]^ (Table [1](#Tab1){ref-type="table"}). The *K*~m~ value of *Sy*CS for acetyl-CoA was similar to that of CS from *Arthrobacter* strain DS2-3R (200 μM)^[@CR26]^ but higher than those of reported CSs from heterotrophic bacteria (14--200 μM)^[@CR23]--[@CR30]^ (Table [1](#Tab1){ref-type="table"}). Similarly, the *K*~m~ value of *Sy*CS for oxaloacetate was higher than those of CSs from heterotrophic bacteria (4--20 μM)^[@CR23]--[@CR30]^ (Table [1](#Tab1){ref-type="table"}). These observations indicate that *Sy*CS is an inefficient enzyme, similar to malate dehydrogenase from *Synechocystis* 6803 (encoded by *citH*, sll0891), which is involved in the oxidative TCA cycle (Fig. [1](#Fig1){ref-type="fig"})^[@CR31]^. In *Synechocystis* 6803, carbon flux through the TCA cycle is low under heterotrophic, photoheterotrophic, photomixotrophic, and photoautotrophic conditions in contrast to other metabolic pathways such as the glycolysis and oxidative pentose phosphate pathways^[@CR22],[@CR32]--[@CR36]^. The low activity of *Sy*CS may be a factor in the observed low carbon flux through the oxidative TCA cycle in *Synechocystis* 6803. Additionally, CSs from *Thermosulfidibacter takaii* ABI70S6T^[@CR37]^ and *Desulfurella acetivorans*^[@CR38]^ catalyse the backward reaction, the cleavage of citrate. *Sy*CS did not catalyse the backward reaction. This result suggests that *Sy*CS is not involved in the reductive TCA cycle (Fig. [1](#Fig1){ref-type="fig"}).

Monovalent and divalent salts and cellular metabolites altered *Sy*CS activity (Figs [4](#Fig4){ref-type="fig"}--[6](#Fig6){ref-type="fig"}). Monovalent salts activate numerous bacterial CSs^[@CR2]^, while divalent salts inhibit many bacterial CSs^[@CR39],[@CR40]^. In contrast to other bacterial CSs, *Sy*CS was markedly activated by the divalent salts MgCl~2~ and CaCl~2~ rather than monovalent salts (Fig. [4](#Fig4){ref-type="fig"}). Among divalent salts, MnCl~2~ inhibited *Sy*CS (Fig. [4](#Fig4){ref-type="fig"}). In CS from *E. coli*, a higher pH leads to greater activation by 0.1 M KCl^[@CR39]^. In *Sy*CS, a higher pH led to greater activation by 0.1 M KCl and NaCl (Fig. [5a,b](#Fig5){ref-type="fig"}). In contrast, a lower pH led to greater activation by 0.1 M MgCl~2~ and CaCl~2~ (Fig. [5c,d](#Fig5){ref-type="fig"}). In monovalent and divalent salts, MgCl~2~ was the strongest activator of *Sy*CS (Figs [4](#Fig4){ref-type="fig"} and [5](#Fig5){ref-type="fig"}). In the stroma in spinach chloroplasts, free Mg^2+^ concentration is affected by light-dark transition^[@CR41]^. It is expected that free Mg^2+^ concentration in *Synechocystis* 6803 is similarly affected by light-dark transition^[@CR42]^. Therefore, *Sy*CS activity may also be affected by light-dark transition. NADH is a feedback inhibitor of CSs in most Gram-negative bacteria^[@CR1]^. However, *Sy*CS was not inhibited by NADH (Fig. [6](#Fig6){ref-type="fig"}). Phylogenetic analysis revealed that *Sy*CS belongs to a cyanobacterial clade being different from clades of Gram-positive bacteria and Gram-negative bacteria (Fig. [7](#Fig7){ref-type="fig"}). Unlike heterotrophic bacteria, cyanobacteria do not possess 2-oxoglutarate dehydrogenase in the TCA cycle, and *Synechocystis* 6803 is rerouted to produce succinate by two alternate pathways (Fig. [1](#Fig1){ref-type="fig"})^[@CR43],[@CR44]^. Isocitrate dehydrogenase from *Synechocystis* 6803 (encoded by *icd*, slr1289) (Fig. [1](#Fig1){ref-type="fig"}) is specific to NADP^+^ and generates NADPH but not NADH^[@CR45]^. Additionally, malate dehydrogenase from *Synechocystis* 6803 (encoded by *citH*, sll0891) (Fig. [1](#Fig1){ref-type="fig"}) specifically catalyses the reductive reaction generating NAD^+^ but not NADH^[@CR31]^. These previous studies explain why NADH does not function as a feedback inhibitor of *Sy*CS. CIT and 2OG are feedback inhibitors of *Sy*CS and several bacterial CSs^[@CR1],[@CR2],[@CR46]^ (Fig. [6](#Fig6){ref-type="fig"}). We demonstrated that PEP is a unique inhibitor of *Sy*CS (Fig. [6](#Fig6){ref-type="fig"}). In the presence of PEP, the *K*~m~ values of *Sy*CS for both substrates were unchanged and the *k*~cat~ values of *Sy*CS for both substrates were decreased (Table [1](#Tab1){ref-type="table"}). These results indicate that PEP is a non-competitive inhibitor of *Sy*CS. Phosphoenolpyruvate carboxylase from *Synechocystis* 6803 (encoded by *pps*, sll0920) catalyses the carboxylation of PEP to generate oxaloacetate, a substrate of *Sy*CS (encoded by *gltA*, sll0401) and malate dehydrogenase (encoded by *citH*, sll0891) (Fig. [1](#Fig1){ref-type="fig"})^[@CR11]^. The reaction catalysed by phosphoenolpyruvate carboxylase (encoded by *pps*, sll0920) (Fig. [1](#Fig1){ref-type="fig"}) is the rate-limiting step in the production of succinate via the reductive TCA cycle in *Synechocystis* 6803^[@CR9],[@CR10]^. PEP has been suggested to regulate both the oxidative and reductive TCA cycle in *Synechocystis* 6803. The intracellular concentrations of CIT and PEP are much higher than that of 2OG (CIT: 7.3 times, PEP: 8.5 times)^[@CR13]^. In inhibitors of metabolites, CIT and PEP may have large inhibitory effects on *Sy*CS under *in vivo* conditions. While ATP did not alter *Sy*CS activity (Fig. [6](#Fig6){ref-type="fig"}), it acts as a feedback inhibitor for other CSs because of its structural similarity with acetyl-CoA^[@CR1],[@CR2]^. In terms of activators, AMP upregulates the activity of CSs from *Azotobacter vinelandii*^[@CR47]^ and *Streptomyces diastaticus* No. 7 strain M1033^[@CR24]^. However, *Sy*CS was activated by ADP rather than AMP (Fig. [6](#Fig6){ref-type="fig"}). ADP enhanced the catalytic efficiency (*k*~cat~/*K*~m~) of *Sy*CS (Table [1](#Tab1){ref-type="table"}). Generally, ADP inhibits CS for the same reason as ATP^[@CR1],[@CR2]^. Our study indicates that ADP is a unique activator of *Sy*CS. *Synechocystis* 6803 has more ADP than ATP in the cells^[@CR13]^ in contrast to *E. coli*^[@CR48]^ whose CS is inhibited by ATP and hardly affected by ADP^[@CR49]^. This may be a reason that *Sy*CS is affected by not ATP but ADP.Figure 7Phylogenetic analysis of bacterial CS. Sequences of 23 bacterial CS obtained from GenBank were aligned using CLC Sequence Viewer ver. 8.0. A maximum-likelihood tree based on 357 preserved amino acid residues was designed using PhyML online (<http://www.atgc-montpellier.fr/phyml/>). Bootstrap values were calculated by 500 replications.

Taken together, we found that the characteristics of *Sy*CS significantly differ from those of other bacterial CSs.

Methods {#Sec7}
=======

Construction of the recombinant *Sy*CS expression vector {#Sec8}
--------------------------------------------------------

The region containing *gltA* (sll0401, encoding *Sy*CS) in the *Synechocystis* 6803 genome was commercially synthesized by Eurofin Genomics Japan (Tokyo, Japan) and cloned into the BamHI-XhoI site of the pGEX5X-1 vector (GE Healthcare, Little Chalfont, UK).

Affinity purification of recombinant proteins {#Sec9}
---------------------------------------------

The expression vector was transformed into *E. coli* DH5α cells (TakaraBio, Shiga, Japan). A 2-L culture of transformed DH5α cells in LB media was prepared by shaking at 125 rpm at 30 °C overnight. Expression of the recombinant proteins was induced by 0.01 mM isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside (Wako Chemicals, Osaka, Japan). Affinity purification of the recombinant proteins was performed as described previously^[@CR12]^. The DH5α cells were lysed by sonication (VC-750, EYELA, Tokyo, Japan) for 200 s at 20% intensity. The supernatant was collected after centrifugation (5,800 × *g* for 2 min at 4 °C) and 560 μL of Glutathione-Sepharose 4B resin (GE Healthcare) was added to the supernatant. The mixture was incubated on ice for 30 min with constant shaking. After 30 min, 1 mM ATP and 1 mM MgSO~4~·7H~2~O were added to the mixture and shaken for 30 min at 37 °C. After centrifugation (5,800 × *g* for 2 min at 4 °C) to remove the supernatant, the resin was re-suspended in 700 μL of PBS-T (1.37 M NaCl, 27 mM KCl, 81 mM Na~2~HPO~4~·12H~2~O, 14.7 mM KH~2~PO~4~, and 0.05% Tween-20) with 1 mM ATP/1 mM MgSO~4~·7H~2~O. The resin was washed 10 times using PBS-T, and the recombinant proteins were eluted with 700 μL of GST elution buffer (50 mM Tris-HCl, pH 8.0, and 10 mM reduced glutathione) four times. The eluted protein fractions were concentrated using a VivaSpin 500 MWCO 50000 device (Sartorius, Göttingen, Germany). The protein concentration was measured using a Pierce BCA Protein Assay Kit (Rockford, IL, USA). To evaluate protein purity, SDS-PAGE followed by staining with InstantBlue (Expedion Protein Solutions, San Diego, CA, USA) was performed.

Enzyme assays {#Sec10}
-------------

The enzyme activity of *Sy*CS for the forward reaction, generating citrate and CoA from acetyl-CoA and oxaloacetate, was assessed as described previously^[@CR50]^. Enzyme activity was calculated by measuring the change in *A*~412~ using a Hitachi U-3310 spectrophotometer (Tokyo, Japan). The purified *Sy*CS proteins were added to 1 mL assay solution \[50 mM Tris-HCl containing various concentrations of oxaloacetate, various concentrations of acetyl-CoA, and 0.2 mM DTNB\]. The *K*~m~ and *V*~max~ values of *Sy*CS were calculated using a Lineweaver-Burk double reciprocal plot. The *k*~cat~ values of *Sy*CS were determined from the *V*~max~ values of *Sy*CS. The enzyme activity of *Sy*CS for the backward reaction, generating acetyl-CoA and oxaloacetate from citrate and CoA, was assessed as described previously^[@CR38]^ by measuring the change in *A*~365~ using a Hitachi U-3310 spectrophotometer. The purified *Sy*CS proteins were added to 1 mL assay solution \[50 mM Tris-HCl containing 1 mM CoA, 1 mM citrate, 5 mM MgCl~2~, 0.5 mM NADH, and 20 U malate dehydrogenase (Oriental Yeast, Tokyo, Japan)\].
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